 Steven Edmundowicz
Concepts (469)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endoscopy, Gastrointestinal | 29 | 2023 | 202 | 3.980 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 35 | 2024 | 182 | 3.550 |
Why?
| | Endosonography | 29 | 2023 | 140 | 2.210 |
Why?
| | Bariatric Surgery | 12 | 2019 | 162 | 2.100 |
Why?
| | Esophageal Neoplasms | 13 | 2022 | 273 | 1.930 |
Why?
| | Pancreatic Neoplasms | 20 | 2023 | 722 | 1.910 |
Why?
| | Endoscopy, Digestive System | 16 | 2021 | 109 | 1.880 |
Why?
| | Adenoma | 12 | 2023 | 187 | 1.630 |
Why?
| | Endoscopy | 13 | 2020 | 246 | 1.620 |
Why?
| | Weight Loss | 11 | 2019 | 641 | 1.550 |
Why?
| | Obesity | 17 | 2019 | 2524 | 1.510 |
Why?
| | Gastric Balloon | 6 | 2018 | 12 | 1.460 |
Why?
| | Gastroplasty | 5 | 2019 | 26 | 1.360 |
Why?
| | Adenocarcinoma | 13 | 2023 | 795 | 1.270 |
Why?
| | Gastrointestinal Hemorrhage | 4 | 2019 | 102 | 1.240 |
Why?
| | Stomach Neoplasms | 5 | 2020 | 65 | 1.170 |
Why?
| | Barrett Esophagus | 10 | 2022 | 147 | 1.160 |
Why?
| | Colonic Neoplasms | 6 | 2015 | 222 | 1.100 |
Why?
| | Endoscopic Ultrasound-Guided Fine Needle Aspiration | 9 | 2019 | 52 | 1.100 |
Why?
| | Drainage | 11 | 2023 | 151 | 1.030 |
Why?
| | Gastroenterology | 10 | 2019 | 158 | 1.020 |
Why?
| | Colonoscopy | 12 | 2023 | 204 | 1.000 |
Why?
| | Colonic Polyps | 7 | 2015 | 67 | 1.000 |
Why?
| | Gastroesophageal Reflux | 11 | 2020 | 233 | 0.930 |
Why?
| | Bile Duct Neoplasms | 4 | 2020 | 56 | 0.910 |
Why?
| | Pancreatitis | 11 | 2024 | 107 | 0.840 |
Why?
| | Stents | 16 | 2024 | 476 | 0.820 |
Why?
| | Gastrointestinal Diseases | 4 | 2022 | 182 | 0.780 |
Why?
| | Pancreatic Ducts | 8 | 2022 | 69 | 0.760 |
Why?
| | Cholestasis | 3 | 2020 | 224 | 0.760 |
Why?
| | Duodenum | 4 | 2019 | 63 | 0.730 |
Why?
| | Duodenoscopes | 2 | 2020 | 7 | 0.730 |
Why?
| | Obesity, Morbid | 7 | 2019 | 198 | 0.720 |
Why?
| | Humans | 156 | 2024 | 115042 | 0.710 |
Why?
| | Esophagus | 8 | 2019 | 226 | 0.710 |
Why?
| | Middle Aged | 88 | 2022 | 26827 | 0.700 |
Why?
| | Pancreatic Diseases | 6 | 2023 | 64 | 0.680 |
Why?
| | Biliary Tract Neoplasms | 1 | 2019 | 20 | 0.680 |
Why?
| | Clinical Competence | 11 | 2020 | 899 | 0.680 |
Why?
| | Biopsy, Fine-Needle | 8 | 2017 | 64 | 0.660 |
Why?
| | Pancreatic Pseudocyst | 4 | 2018 | 13 | 0.630 |
Why?
| | Aged | 67 | 2022 | 19119 | 0.620 |
Why?
| | Cross Infection | 1 | 2020 | 199 | 0.600 |
Why?
| | Gastrostomy | 5 | 2019 | 89 | 0.590 |
Why?
| | Learning Curve | 6 | 2019 | 63 | 0.590 |
Why?
| | Endoscopic Mucosal Resection | 5 | 2022 | 22 | 0.580 |
Why?
| | Radiation Exposure | 1 | 2017 | 41 | 0.580 |
Why?
| | Intestine, Small | 2 | 2020 | 122 | 0.570 |
Why?
| | Prospective Studies | 35 | 2023 | 6232 | 0.570 |
Why?
| | Colonic Diseases | 3 | 2013 | 25 | 0.550 |
Why?
| | Radiation Injuries | 1 | 2017 | 127 | 0.550 |
Why?
| | Jejunum | 2 | 2015 | 24 | 0.540 |
Why?
| | Treatment Outcome | 34 | 2023 | 9122 | 0.520 |
Why?
| | Self Expandable Metallic Stents | 3 | 2022 | 14 | 0.510 |
Why?
| | Smell | 1 | 2016 | 112 | 0.510 |
Why?
| | Male | 89 | 2023 | 55731 | 0.510 |
Why?
| | Pathology, Clinical | 1 | 2015 | 32 | 0.510 |
Why?
| | Gastrointestinal Neoplasms | 2 | 2013 | 60 | 0.510 |
Why?
| | Pancreas | 7 | 2021 | 280 | 0.500 |
Why?
| | Laparoscopy | 6 | 2020 | 387 | 0.500 |
Why?
| | Pancreatitis, Chronic | 4 | 2022 | 40 | 0.490 |
Why?
| | Cholelithiasis | 8 | 2010 | 31 | 0.490 |
Why?
| | Female | 91 | 2023 | 59613 | 0.490 |
Why?
| | Suction | 2 | 2017 | 31 | 0.480 |
Why?
| | Catheter Ablation | 5 | 2022 | 291 | 0.470 |
Why?
| | Postoperative Hemorrhage | 3 | 2017 | 75 | 0.460 |
Why?
| | Esophagoscopy | 8 | 2022 | 183 | 0.450 |
Why?
| | Gallstones | 6 | 1996 | 28 | 0.450 |
Why?
| | Adult | 58 | 2024 | 30656 | 0.430 |
Why?
| | Lithotripsy | 5 | 2019 | 40 | 0.430 |
Why?
| | Catheterization | 8 | 2019 | 159 | 0.420 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2017 | 2098 | 0.420 |
Why?
| | Sensitivity and Specificity | 11 | 2019 | 1715 | 0.420 |
Why?
| | Propofol | 4 | 2023 | 43 | 0.420 |
Why?
| | Colorectal Neoplasms | 5 | 2022 | 617 | 0.410 |
Why?
| | Body Weight | 1 | 2016 | 873 | 0.410 |
Why?
| | Biopsy | 5 | 2019 | 1046 | 0.380 |
Why?
| | Precancerous Conditions | 4 | 2017 | 156 | 0.380 |
Why?
| | Gastroscopy | 4 | 2014 | 18 | 0.380 |
Why?
| | Aged, 80 and over | 22 | 2019 | 6357 | 0.370 |
Why?
| | Quality Indicators, Health Care | 5 | 2018 | 287 | 0.370 |
Why?
| | Postoperative Complications | 10 | 2021 | 2150 | 0.360 |
Why?
| | Bile Ducts | 5 | 2014 | 71 | 0.360 |
Why?
| | Indomethacin | 2 | 2024 | 75 | 0.360 |
Why?
| | Duodenal Neoplasms | 2 | 2023 | 19 | 0.350 |
Why?
| | Ampulla of Vater | 3 | 2023 | 29 | 0.350 |
Why?
| | Pancreatic Cyst | 3 | 2018 | 47 | 0.350 |
Why?
| | Cytodiagnosis | 2 | 2020 | 29 | 0.350 |
Why?
| | Pancreatitis, Acute Necrotizing | 3 | 2023 | 11 | 0.340 |
Why?
| | Constriction, Pathologic | 6 | 2022 | 210 | 0.330 |
Why?
| | Insufflation | 1 | 2009 | 9 | 0.330 |
Why?
| | Retrospective Studies | 34 | 2023 | 12547 | 0.320 |
Why?
| | In Situ Hybridization, Fluorescence | 2 | 2020 | 310 | 0.320 |
Why?
| | Common Bile Duct Neoplasms | 2 | 2023 | 23 | 0.320 |
Why?
| | Esophagogastric Junction | 3 | 2019 | 42 | 0.320 |
Why?
| | Cholecystectomy, Laparoscopic | 6 | 2008 | 45 | 0.310 |
Why?
| | Carbon Dioxide | 1 | 2009 | 218 | 0.290 |
Why?
| | Pain, Postoperative | 1 | 2009 | 193 | 0.290 |
Why?
| | Calculi | 3 | 2019 | 16 | 0.290 |
Why?
| | Decompression, Surgical | 2 | 2023 | 93 | 0.290 |
Why?
| | Body Mass Index | 7 | 2019 | 1967 | 0.280 |
Why?
| | Pancreatectomy | 2 | 2021 | 169 | 0.280 |
Why?
| | Prosthesis Implantation | 3 | 2019 | 138 | 0.280 |
Why?
| | Gastrointestinal Stromal Tumors | 3 | 2015 | 43 | 0.280 |
Why?
| | Sphincterotomy, Endoscopic | 6 | 2019 | 24 | 0.280 |
Why?
| | Neoplasm Recurrence, Local | 4 | 2023 | 856 | 0.270 |
Why?
| | Follow-Up Studies | 16 | 2015 | 4420 | 0.270 |
Why?
| | Endoscopes, Gastrointestinal | 1 | 2006 | 12 | 0.260 |
Why?
| | Thoracoscopy | 1 | 2006 | 53 | 0.260 |
Why?
| | Neuroendocrine Tumors | 2 | 2018 | 83 | 0.260 |
Why?
| | Early Detection of Cancer | 5 | 2022 | 339 | 0.260 |
Why?
| | Mental Recall | 1 | 2006 | 170 | 0.250 |
Why?
| | Societies, Medical | 3 | 2018 | 678 | 0.240 |
Why?
| | Esophageal Sphincter, Lower | 2 | 2015 | 10 | 0.230 |
Why?
| | Polyvinyls | 1 | 2004 | 17 | 0.230 |
Why?
| | Plastics | 3 | 2022 | 35 | 0.230 |
Why?
| | Magnets | 2 | 2015 | 15 | 0.230 |
Why?
| | Periodicals as Topic | 1 | 2006 | 181 | 0.230 |
Why?
| | Gastric Bypass | 2 | 2017 | 93 | 0.230 |
Why?
| | Ablation Techniques | 3 | 2017 | 29 | 0.210 |
Why?
| | Common Bile Duct | 3 | 2009 | 14 | 0.210 |
Why?
| | Internet | 2 | 2009 | 600 | 0.210 |
Why?
| | Patient Satisfaction | 1 | 2006 | 580 | 0.210 |
Why?
| | Carcinoma, Pancreatic Ductal | 3 | 2017 | 208 | 0.210 |
Why?
| | Fluoroscopy | 3 | 2019 | 141 | 0.200 |
Why?
| | Anesthesia | 1 | 2023 | 118 | 0.200 |
Why?
| | Prostheses and Implants | 3 | 2013 | 139 | 0.200 |
Why?
| | Pneumonia, Aspiration | 2 | 2019 | 15 | 0.200 |
Why?
| | Deglutition Disorders | 3 | 2019 | 119 | 0.190 |
Why?
| | Double-Blind Method | 7 | 2018 | 1664 | 0.190 |
Why?
| | Prosthesis Design | 3 | 2019 | 285 | 0.190 |
Why?
| | Quality of Life | 10 | 2019 | 2359 | 0.190 |
Why?
| | Intestinal Perforation | 2 | 2018 | 38 | 0.180 |
Why?
| | Carcinoembryonic Antigen | 3 | 2018 | 37 | 0.180 |
Why?
| | Varicose Veins | 1 | 2020 | 14 | 0.180 |
Why?
| | Neoplasm Staging | 5 | 2017 | 1169 | 0.180 |
Why?
| | Esophageal and Gastric Varices | 1 | 2020 | 33 | 0.180 |
Why?
| | Biliary Tract Diseases | 4 | 2014 | 33 | 0.170 |
Why?
| | Deep Sedation | 2 | 2010 | 10 | 0.170 |
Why?
| | Abdominal Pain | 3 | 2019 | 135 | 0.170 |
Why?
| | Cell-Free System | 1 | 2019 | 47 | 0.170 |
Why?
| | Equipment Design | 6 | 2020 | 513 | 0.170 |
Why?
| | Liver Neoplasms | 1 | 2023 | 516 | 0.170 |
Why?
| | Fiducial Markers | 1 | 2019 | 8 | 0.170 |
Why?
| | Urinary Calculi | 1 | 2019 | 11 | 0.170 |
Why?
| | Watchful Waiting | 3 | 2019 | 56 | 0.160 |
Why?
| | Radiotherapy, Image-Guided | 1 | 2019 | 30 | 0.160 |
Why?
| | Practice Guidelines as Topic | 2 | 2018 | 1398 | 0.160 |
Why?
| | Academic Medical Centers | 3 | 2023 | 412 | 0.160 |
Why?
| | Needles | 1 | 2019 | 51 | 0.160 |
Why?
| | Infection Control | 1 | 2020 | 135 | 0.160 |
Why?
| | Metals | 4 | 2023 | 107 | 0.160 |
Why?
| | Esophageal Stenosis | 1 | 2019 | 44 | 0.160 |
Why?
| | Reproducibility of Results | 7 | 2020 | 2799 | 0.160 |
Why?
| | Abdomen | 2 | 2016 | 104 | 0.160 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 2 | 2024 | 299 | 0.150 |
Why?
| | Simulation Training | 1 | 2019 | 62 | 0.150 |
Why?
| | Cystadenoma, Serous | 1 | 2018 | 17 | 0.150 |
Why?
| | Delayed Diagnosis | 1 | 2018 | 71 | 0.150 |
Why?
| | Obesity Management | 1 | 2017 | 8 | 0.150 |
Why?
| | Cystadenoma, Mucinous | 2 | 2015 | 13 | 0.150 |
Why?
| | Aneurysm, False | 1 | 2018 | 45 | 0.150 |
Why?
| | Education, Medical, Graduate | 2 | 2019 | 374 | 0.150 |
Why?
| | Cystadenocarcinoma, Mucinous | 2 | 2015 | 14 | 0.150 |
Why?
| | Conscious Sedation | 2 | 2023 | 79 | 0.150 |
Why?
| | Suture Techniques | 3 | 2017 | 118 | 0.150 |
Why?
| | Pancreaticoduodenectomy | 2 | 2016 | 130 | 0.140 |
Why?
| | Logistic Models | 6 | 2021 | 1839 | 0.140 |
Why?
| | Diagnostic Tests, Routine | 1 | 2018 | 87 | 0.140 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2017 | 88 | 0.140 |
Why?
| | Calcinosis | 1 | 2019 | 242 | 0.140 |
Why?
| | Metaplasia | 4 | 2022 | 54 | 0.140 |
Why?
| | Immunoassay | 1 | 2017 | 95 | 0.140 |
Why?
| | Diet Therapy | 1 | 2016 | 36 | 0.140 |
Why?
| | Polymerase Chain Reaction | 1 | 2019 | 999 | 0.140 |
Why?
| | Referral and Consultation | 3 | 2019 | 633 | 0.140 |
Why?
| | Population Surveillance | 2 | 2017 | 392 | 0.140 |
Why?
| | Respiratory Insufficiency | 2 | 2010 | 290 | 0.130 |
Why?
| | Stomach | 1 | 2016 | 101 | 0.130 |
Why?
| | Fellowships and Scholarships | 1 | 2019 | 227 | 0.130 |
Why?
| | Intestinal Mucosa | 3 | 2017 | 528 | 0.130 |
Why?
| | Pilot Projects | 2 | 2013 | 1375 | 0.130 |
Why?
| | Neoplasms, Cystic, Mucinous, and Serous | 1 | 2016 | 25 | 0.130 |
Why?
| | Intubation, Gastrointestinal | 1 | 1996 | 53 | 0.130 |
Why?
| | Bariatric Medicine | 1 | 2015 | 2 | 0.130 |
Why?
| | Risk Factors | 11 | 2024 | 8642 | 0.130 |
Why?
| | Single-Blind Method | 5 | 2019 | 258 | 0.130 |
Why?
| | Dogs | 1 | 2016 | 340 | 0.130 |
Why?
| | Life Style | 2 | 2018 | 431 | 0.130 |
Why?
| | Documentation | 1 | 2017 | 169 | 0.130 |
Why?
| | Colon, Ascending | 1 | 2015 | 3 | 0.130 |
Why?
| | Dissection | 1 | 2015 | 51 | 0.120 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2015 | 52 | 0.120 |
Why?
| | Young Adult | 10 | 2018 | 10498 | 0.120 |
Why?
| | Cholecystectomy | 4 | 2009 | 45 | 0.120 |
Why?
| | Leiomyoma | 1 | 2015 | 45 | 0.120 |
Why?
| | Proton Pump Inhibitors | 3 | 2020 | 96 | 0.120 |
Why?
| | Peristalsis | 2 | 1991 | 30 | 0.120 |
Why?
| | Biomarkers, Tumor | 3 | 2017 | 1045 | 0.120 |
Why?
| | Aptitude | 1 | 2014 | 38 | 0.120 |
Why?
| | Colorectal Surgery | 1 | 2014 | 21 | 0.120 |
Why?
| | Liver Cirrhosis | 2 | 2020 | 235 | 0.120 |
Why?
| | Multivariate Analysis | 4 | 2021 | 1435 | 0.120 |
Why?
| | Ulcer | 1 | 2014 | 28 | 0.110 |
Why?
| | Predictive Value of Tests | 6 | 2016 | 1812 | 0.110 |
Why?
| | Colectomy | 1 | 2014 | 86 | 0.110 |
Why?
| | Hemorrhage | 1 | 2018 | 618 | 0.110 |
Why?
| | Patient Safety | 1 | 2016 | 277 | 0.110 |
Why?
| | Cholangiopancreatography, Magnetic Resonance | 1 | 2013 | 16 | 0.110 |
Why?
| | Anastomosis, Roux-en-Y | 1 | 2013 | 28 | 0.110 |
Why?
| | Multidetector Computed Tomography | 1 | 2013 | 27 | 0.110 |
Why?
| | Exercise Therapy | 1 | 2016 | 351 | 0.110 |
Why?
| | Ultrasonography, Interventional | 2 | 2015 | 123 | 0.110 |
Why?
| | Recurrence | 4 | 2020 | 941 | 0.110 |
Why?
| | Contrast Media | 1 | 1995 | 369 | 0.100 |
Why?
| | Community Health Services | 1 | 2014 | 211 | 0.100 |
Why?
| | Risk Assessment | 8 | 2016 | 2976 | 0.100 |
Why?
| | Bile Duct Diseases | 1 | 2012 | 17 | 0.100 |
Why?
| | Cholecystitis | 1 | 1992 | 17 | 0.100 |
Why?
| | Health Care Costs | 1 | 2015 | 381 | 0.100 |
Why?
| | Lymph Nodes | 2 | 2012 | 422 | 0.100 |
Why?
| | Cholestasis, Extrahepatic | 1 | 1991 | 5 | 0.100 |
Why?
| | Diagnosis, Differential | 6 | 2015 | 1355 | 0.100 |
Why?
| | Diverticulum | 1 | 1991 | 11 | 0.100 |
Why?
| | Duodenal Diseases | 1 | 1991 | 9 | 0.100 |
Why?
| | Digestive System Diseases | 1 | 2011 | 23 | 0.100 |
Why?
| | Time Factors | 8 | 2019 | 6141 | 0.100 |
Why?
| | Esophageal Diseases | 1 | 1991 | 24 | 0.100 |
Why?
| | Sensation | 1 | 1991 | 44 | 0.100 |
Why?
| | United States | 10 | 2018 | 12226 | 0.100 |
Why?
| | Proteomics | 1 | 2017 | 844 | 0.090 |
Why?
| | Severity of Illness Index | 1 | 2019 | 2551 | 0.090 |
Why?
| | Chest Pain | 1 | 1991 | 81 | 0.090 |
Why?
| | Patient Compliance | 1 | 2015 | 524 | 0.090 |
Why?
| | Administration, Rectal | 2 | 2024 | 5 | 0.090 |
Why?
| | Deglutition | 1 | 1991 | 58 | 0.090 |
Why?
| | Disease Progression | 5 | 2017 | 2389 | 0.090 |
Why?
| | Hypotension | 1 | 2011 | 114 | 0.090 |
Why?
| | Muscle, Smooth | 1 | 1991 | 149 | 0.090 |
Why?
| | Hepatic Duct, Common | 1 | 2010 | 5 | 0.090 |
Why?
| | Colonoscopes | 1 | 2009 | 5 | 0.090 |
Why?
| | Image Enhancement | 1 | 2011 | 181 | 0.090 |
Why?
| | Bile | 1 | 2009 | 26 | 0.090 |
Why?
| | Cholecystostomy | 1 | 1989 | 4 | 0.090 |
Why?
| | Odds Ratio | 4 | 2016 | 957 | 0.080 |
Why?
| | Sleep Apnea Syndromes | 1 | 2010 | 74 | 0.080 |
Why?
| | Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2010 | 74 | 0.080 |
Why?
| | Abdominal Neoplasms | 1 | 2009 | 26 | 0.080 |
Why?
| | Anesthetics | 1 | 2009 | 55 | 0.080 |
Why?
| | Mutation | 1 | 2019 | 3350 | 0.080 |
Why?
| | Tumor Burden | 3 | 2015 | 260 | 0.080 |
Why?
| | Loss of Heterozygosity | 1 | 2009 | 41 | 0.080 |
Why?
| | Intestinal Obstruction | 1 | 2009 | 40 | 0.080 |
Why?
| | Equipment Safety | 2 | 2009 | 40 | 0.080 |
Why?
| | Incidence | 5 | 2018 | 2318 | 0.080 |
Why?
| | DNA, Neoplasm | 1 | 2009 | 157 | 0.080 |
Why?
| | Cholangiography | 1 | 2008 | 16 | 0.080 |
Why?
| | Ultrasonography | 4 | 1996 | 636 | 0.080 |
Why?
| | Choledocholithiasis | 1 | 2008 | 14 | 0.080 |
Why?
| | Feeding Behavior | 1 | 2013 | 574 | 0.080 |
Why?
| | Video Recording | 3 | 2014 | 145 | 0.080 |
Why?
| | Quality Assurance, Health Care | 1 | 2010 | 314 | 0.070 |
Why?
| | Health Services Research | 1 | 2010 | 371 | 0.070 |
Why?
| | Registries | 1 | 2015 | 1763 | 0.070 |
Why?
| | Positron-Emission Tomography | 1 | 2008 | 275 | 0.070 |
Why?
| | Acute Disease | 4 | 2008 | 915 | 0.070 |
Why?
| | Biopsy, Needle | 2 | 2004 | 183 | 0.070 |
Why?
| | Delphi Technique | 2 | 2017 | 163 | 0.070 |
Why?
| | Prognosis | 5 | 2017 | 3334 | 0.070 |
Why?
| | Research Design | 2 | 2016 | 930 | 0.070 |
Why?
| | Adolescent | 7 | 2024 | 17864 | 0.070 |
Why?
| | Hyperplasia | 2 | 2019 | 165 | 0.070 |
Why?
| | Pleural Diseases | 1 | 2006 | 21 | 0.070 |
Why?
| | Pancreatic Fistula | 1 | 2006 | 21 | 0.070 |
Why?
| | Hypoxia | 1 | 2011 | 958 | 0.060 |
Why?
| | Cohort Studies | 5 | 2020 | 4904 | 0.060 |
Why?
| | Pain | 2 | 2022 | 709 | 0.060 |
Why?
| | Surveys and Questionnaires | 4 | 2015 | 4631 | 0.060 |
Why?
| | Hospital Units | 1 | 2004 | 23 | 0.060 |
Why?
| | Health Care Surveys | 3 | 2014 | 538 | 0.060 |
Why?
| | Tertiary Care Centers | 2 | 2016 | 126 | 0.060 |
Why?
| | Cyst Fluid | 2 | 2018 | 27 | 0.060 |
Why?
| | Diphenhydramine | 1 | 2023 | 30 | 0.060 |
Why?
| | Midazolam | 1 | 2023 | 43 | 0.060 |
Why?
| | Efficiency, Organizational | 1 | 2004 | 124 | 0.060 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2008 | 577 | 0.060 |
Why?
| | Observer Variation | 2 | 2014 | 298 | 0.050 |
Why?
| | Mass Screening | 1 | 2010 | 1012 | 0.050 |
Why?
| | Animals | 3 | 2020 | 31867 | 0.050 |
Why?
| | Disposable Equipment | 2 | 2009 | 15 | 0.050 |
Why?
| | Fentanyl | 1 | 2023 | 65 | 0.050 |
Why?
| | Missouri | 2 | 2014 | 63 | 0.050 |
Why?
| | Neoplasms | 1 | 2016 | 2106 | 0.050 |
Why?
| | Electrocoagulation | 1 | 2023 | 38 | 0.050 |
Why?
| | Hypnotics and Sedatives | 1 | 2023 | 134 | 0.050 |
Why?
| | Necrosis | 1 | 2023 | 210 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 3 | 2006 | 2341 | 0.050 |
Why?
| | Esophagitis, Peptic | 1 | 2002 | 16 | 0.050 |
Why?
| | Guidelines as Topic | 2 | 2015 | 245 | 0.050 |
Why?
| | Length of Stay | 4 | 2018 | 950 | 0.050 |
Why?
| | Hyperthermia, Induced | 1 | 2002 | 65 | 0.050 |
Why?
| | Endoscopes | 2 | 1998 | 18 | 0.050 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 2001 | 49 | 0.050 |
Why?
| | Cholestasis, Intrahepatic | 1 | 2001 | 39 | 0.050 |
Why?
| | Lumbar Vertebrae | 1 | 2023 | 212 | 0.050 |
Why?
| | Feasibility Studies | 2 | 2018 | 746 | 0.050 |
Why?
| | Silicones | 1 | 2020 | 20 | 0.050 |
Why?
| | Combined Modality Therapy | 2 | 2016 | 1127 | 0.040 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2000 | 38 | 0.040 |
Why?
| | Hemostatic Techniques | 1 | 2000 | 40 | 0.040 |
Why?
| | Los Angeles | 1 | 2020 | 56 | 0.040 |
Why?
| | Fundoplication | 1 | 2020 | 51 | 0.040 |
Why?
| | Technology Assessment, Biomedical | 5 | 1998 | 29 | 0.040 |
Why?
| | Contraindications | 2 | 2017 | 86 | 0.040 |
Why?
| | Equivalence Trials as Topic | 1 | 2019 | 6 | 0.040 |
Why?
| | Clinical Trials as Topic | 2 | 2015 | 937 | 0.040 |
Why?
| | Microscopy, Confocal | 1 | 2020 | 305 | 0.040 |
Why?
| | General Surgery | 1 | 2000 | 127 | 0.040 |
Why?
| | Adenocarcinoma, Mucinous | 2 | 2009 | 61 | 0.040 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2006 | 1184 | 0.040 |
Why?
| | Practice Patterns, Physicians' | 3 | 2014 | 1177 | 0.040 |
Why?
| | Probability | 2 | 2009 | 289 | 0.040 |
Why?
| | Electrodes | 1 | 1998 | 100 | 0.040 |
Why?
| | Electrosurgery | 1 | 1998 | 43 | 0.040 |
Why?
| | Resuscitation | 1 | 2000 | 247 | 0.040 |
Why?
| | Swine | 1 | 2020 | 704 | 0.040 |
Why?
| | Reference Standards | 1 | 2018 | 159 | 0.040 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2018 | 71 | 0.040 |
Why?
| | Surgical Instruments | 1 | 2018 | 48 | 0.040 |
Why?
| | Statistics, Nonparametric | 2 | 2008 | 387 | 0.040 |
Why?
| | Radiology | 1 | 2000 | 193 | 0.040 |
Why?
| | Granulation Tissue | 1 | 2016 | 6 | 0.040 |
Why?
| | Manometry | 2 | 2001 | 89 | 0.040 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2008 | 152 | 0.030 |
Why?
| | Prevalence | 2 | 2015 | 2255 | 0.030 |
Why?
| | Patient Reported Outcome Measures | 1 | 2019 | 250 | 0.030 |
Why?
| | Organizational Policy | 1 | 2017 | 68 | 0.030 |
Why?
| | Surgery, Computer-Assisted | 1 | 2017 | 63 | 0.030 |
Why?
| | Patient Admission | 1 | 2018 | 175 | 0.030 |
Why?
| | Longitudinal Studies | 2 | 2015 | 2389 | 0.030 |
Why?
| | Child, Preschool | 2 | 2022 | 9093 | 0.030 |
Why?
| | Gastric Fistula | 1 | 1996 | 4 | 0.030 |
Why?
| | Neoplasm Seeding | 1 | 1996 | 7 | 0.030 |
Why?
| | Survival Rate | 1 | 2000 | 1646 | 0.030 |
Why?
| | Cystic Duct | 1 | 1996 | 3 | 0.030 |
Why?
| | Fasciitis, Necrotizing | 1 | 1996 | 9 | 0.030 |
Why?
| | Intestinal Fistula | 1 | 1996 | 11 | 0.030 |
Why?
| | Tissue Banks | 1 | 2016 | 18 | 0.030 |
Why?
| | Cutaneous Fistula | 1 | 1996 | 13 | 0.030 |
Why?
| | Patient Care Team | 1 | 2000 | 515 | 0.030 |
Why?
| | Diatrizoate Meglumine | 1 | 1995 | 3 | 0.030 |
Why?
| | Foreign-Body Migration | 1 | 1996 | 37 | 0.030 |
Why?
| | Digestive System | 1 | 1995 | 27 | 0.030 |
Why?
| | Iopamidol | 1 | 1995 | 13 | 0.030 |
Why?
| | Weight Reduction Programs | 1 | 2017 | 94 | 0.030 |
Why?
| | Decision Trees | 1 | 2015 | 81 | 0.030 |
Why?
| | Image-Guided Biopsy | 1 | 2015 | 33 | 0.030 |
Why?
| | Peritonitis | 1 | 1996 | 76 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2022 | 799 | 0.030 |
Why?
| | Quality-Adjusted Life Years | 1 | 2015 | 101 | 0.030 |
Why?
| | Markov Chains | 1 | 2015 | 114 | 0.030 |
Why?
| | Osmolar Concentration | 1 | 1995 | 174 | 0.030 |
Why?
| | Netherlands | 1 | 2015 | 65 | 0.030 |
Why?
| | Behavior Therapy | 1 | 2017 | 227 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 1 | 2006 | 3118 | 0.030 |
Why?
| | Costs and Cost Analysis | 1 | 2015 | 196 | 0.030 |
Why?
| | Consensus | 1 | 2017 | 534 | 0.030 |
Why?
| | Lipids | 1 | 2018 | 586 | 0.030 |
Why?
| | Clinical Protocols | 1 | 2016 | 234 | 0.030 |
Why?
| | Incidental Findings | 1 | 2015 | 76 | 0.030 |
Why?
| | Enteral Nutrition | 1 | 1995 | 157 | 0.030 |
Why?
| | Confidence Intervals | 1 | 2015 | 306 | 0.030 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2014 | 79 | 0.030 |
Why?
| | Advisory Committees | 1 | 2015 | 208 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2018 | 618 | 0.030 |
Why?
| | ROC Curve | 1 | 2015 | 447 | 0.030 |
Why?
| | Patient Participation | 1 | 2017 | 360 | 0.030 |
Why?
| | Monitoring, Physiologic | 1 | 1995 | 249 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2017 | 1081 | 0.030 |
Why?
| | Medicaid | 1 | 2017 | 409 | 0.030 |
Why?
| | Health Status Indicators | 1 | 2014 | 154 | 0.030 |
Why?
| | Patient Selection | 1 | 2017 | 646 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2015 | 544 | 0.030 |
Why?
| | Program Evaluation | 1 | 2017 | 825 | 0.030 |
Why?
| | Palliative Care | 1 | 2019 | 639 | 0.030 |
Why?
| | Evidence-Based Medicine | 1 | 2017 | 676 | 0.030 |
Why?
| | Sphincter of Oddi | 1 | 2012 | 4 | 0.030 |
Why?
| | Radio Waves | 2 | 2003 | 16 | 0.030 |
Why?
| | Colic | 1 | 1992 | 6 | 0.030 |
Why?
| | Mucous Membrane | 1 | 2013 | 108 | 0.030 |
Why?
| | Medicare | 1 | 2017 | 666 | 0.030 |
Why?
| | Mediastinum | 1 | 2012 | 21 | 0.030 |
Why?
| | Esophagitis | 1 | 2013 | 65 | 0.030 |
Why?
| | Adenoma, Villous | 1 | 2012 | 2 | 0.030 |
Why?
| | Blood Pressure | 1 | 2018 | 1539 | 0.030 |
Why?
| | Decision Support Techniques | 1 | 2015 | 351 | 0.030 |
Why?
| | Anesthetics, Intravenous | 1 | 2011 | 27 | 0.020 |
Why?
| | Injections, Intravenous | 1 | 2011 | 202 | 0.020 |
Why?
| | Heartburn | 2 | 2001 | 11 | 0.020 |
Why?
| | Edema | 1 | 2011 | 119 | 0.020 |
Why?
| | Polyethylene | 1 | 2010 | 9 | 0.020 |
Why?
| | Body Height | 1 | 1991 | 180 | 0.020 |
Why?
| | Preoperative Care | 1 | 1992 | 318 | 0.020 |
Why?
| | Diet | 1 | 2017 | 1076 | 0.020 |
Why?
| | Gastroscopes | 1 | 2010 | 3 | 0.020 |
Why?
| | Epithelium | 1 | 2011 | 297 | 0.020 |
Why?
| | Esophageal pH Monitoring | 1 | 2010 | 22 | 0.020 |
Why?
| | Duodenoscopy | 1 | 2009 | 7 | 0.020 |
Why?
| | Methods | 1 | 1989 | 59 | 0.020 |
Why?
| | Punctures | 1 | 1989 | 36 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2001 | 512 | 0.020 |
Why?
| | Radiography | 1 | 1992 | 827 | 0.020 |
Why?
| | Reference Values | 1 | 1991 | 748 | 0.020 |
Why?
| | Injections | 1 | 2010 | 159 | 0.020 |
Why?
| | Psychiatric Status Rating Scales | 1 | 1991 | 484 | 0.020 |
Why?
| | Adenocarcinoma, Papillary | 1 | 2009 | 9 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2009 | 63 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2011 | 814 | 0.020 |
Why?
| | Light | 1 | 2011 | 335 | 0.020 |
Why?
| | Nervous System Diseases | 1 | 1991 | 252 | 0.020 |
Why?
| | Age Distribution | 1 | 2009 | 340 | 0.020 |
Why?
| | Sex Distribution | 1 | 2009 | 335 | 0.020 |
Why?
| | ras Proteins | 1 | 2009 | 138 | 0.020 |
Why?
| | Radiopharmaceuticals | 1 | 2008 | 164 | 0.020 |
Why?
| | Muscle Contraction | 1 | 1991 | 399 | 0.020 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2008 | 123 | 0.020 |
Why?
| | Age Factors | 1 | 2015 | 2894 | 0.020 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 228 | 0.020 |
Why?
| | Specimen Handling | 1 | 2009 | 155 | 0.020 |
Why?
| | Decision Making | 1 | 2014 | 782 | 0.020 |
Why?
| | Intraoperative Complications | 1 | 2008 | 124 | 0.020 |
Why?
| | Exercise | 1 | 2017 | 1644 | 0.020 |
Why?
| | Safety Management | 1 | 2007 | 109 | 0.020 |
Why?
| | Early Diagnosis | 1 | 2008 | 218 | 0.020 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2009 | 311 | 0.020 |
Why?
| | Thoracic Surgery | 1 | 2008 | 105 | 0.020 |
Why?
| | Cross-Sectional Studies | 2 | 2008 | 4411 | 0.020 |
Why?
| | Survival Analysis | 1 | 2009 | 1211 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2008 | 1229 | 0.020 |
Why?
| | Proto-Oncogene Proteins | 1 | 2009 | 609 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2009 | 1634 | 0.020 |
Why?
| | Infant | 1 | 2018 | 7946 | 0.020 |
Why?
| | Child | 2 | 2018 | 18407 | 0.020 |
Why?
| | Comorbidity | 1 | 2009 | 1457 | 0.010 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2004 | 79 | 0.010 |
Why?
| | Sex Factors | 1 | 2009 | 1721 | 0.010 |
Why?
| | False Negative Reactions | 1 | 2002 | 50 | 0.010 |
Why?
| | Reoperation | 2 | 1996 | 519 | 0.010 |
Why?
| | Gastric Acidity Determination | 1 | 2002 | 7 | 0.010 |
Why?
| | Attitude of Health Personnel | 1 | 2009 | 976 | 0.010 |
Why?
| | Cholangiocarcinoma | 1 | 2001 | 38 | 0.010 |
Why?
| | Energy Transfer | 1 | 2001 | 47 | 0.010 |
Why?
| | Computer Simulation | 1 | 2004 | 880 | 0.010 |
Why?
| | Equipment Failure | 1 | 1998 | 107 | 0.010 |
Why?
| | Safety | 1 | 1998 | 297 | 0.010 |
Why?
| | Radiology, Interventional | 1 | 1996 | 27 | 0.010 |
Why?
| | Oximetry | 1 | 1995 | 81 | 0.010 |
Why?
| | Blood Pressure Determination | 1 | 1995 | 122 | 0.010 |
Why?
| | Electrocardiography | 1 | 1995 | 562 | 0.010 |
Why?
| | Technetium Tc 99m Disofenin | 1 | 1992 | 3 | 0.010 |
Why?
| | Sincalide | 1 | 1992 | 5 | 0.010 |
Why?
| | Organotechnetium Compounds | 1 | 1992 | 10 | 0.010 |
Why?
| | Imino Acids | 1 | 1992 | 5 | 0.010 |
Why?
| | Gallbladder | 1 | 1992 | 14 | 0.010 |
Why?
| | Radionuclide Imaging | 1 | 1992 | 115 | 0.010 |
Why?
| | Aniline Compounds | 1 | 1992 | 71 | 0.010 |
Why?
| | Glycine | 1 | 1992 | 153 | 0.010 |
Why?
| | Chronic Disease | 1 | 1995 | 1591 | 0.010 |
Why?
| | Pregnancy | 1 | 2001 | 5520 | 0.010 |
Why?
|
|
Edmundowicz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|